These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12576313)

  • 1. TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin.
    Herling M; Teitell MA; Shen RR; Medeiros LJ; Jones D
    Blood; 2003 Jun; 101(12):5007-9. PubMed ID: 12576313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hematodermic CD4/CD56 neoplasm].
    Petrella T; Wechsler J; Courville P; de Muret A; Bosq J; Déchelotte P; Feuillard J; Durlach A; Vergier B
    Ann Pathol; 2004 Jun; 24(3):241-55; quiz 227. PubMed ID: 15480259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes.
    Petrella T; Comeau MR; Maynadié M; Couillault G; De Muret A; Maliszewski CR; Dalac S; Durlach A; Galibert L
    Am J Surg Pathol; 2002 Jul; 26(7):852-62. PubMed ID: 12131152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Agranular CD4+ CD56+ CD123+ hematodermic neoplasm (blastic NK-cell lymphoma) revealed by cutaneous localization: 2 cases].
    Machet L; De Muret A; Wiezberka E; Bernez A; Abdallah-Lotf M; Linassier C; Petrella T
    Ann Dermatol Venereol; 2004 Nov; 131(11):969-73. PubMed ID: 15602384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.
    Petrella T; Meijer CJ; Dalac S; Willemze R; Maynadié M; Machet L; Casasnovas O; Vergier B; Teitell MA
    Am J Clin Pathol; 2004 Aug; 122(2):307-13. PubMed ID: 15323148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.
    Khoury JD; Medeiros LJ; Manning JT; Sulak LE; Bueso-Ramos C; Jones D
    Cancer; 2002 May; 94(9):2401-8. PubMed ID: 12015765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD123+CD4+CD56+ neoplasm: blastic plasmacytoid dendritic cell neoplasm or acute myeloid leukemia?
    Wang W; Thakral B
    Blood; 2020 Sep; 136(13):1565. PubMed ID: 32970810
    [No Abstract]   [Full Text] [Related]  

  • 8. An unusual case of CD4+ CD7+ CD56+ acute leukemia with overlapping features of type 2 dendritic cell (DC2) and myeloid/NK cell precursor acute leukemia.
    Anargyrou K; Paterakis G; Boutsis D; Politou M; Papadhimitriou SI; Siakandaris M; Vassiliadis J; Androulakis A; Meletis J; Rombos J; Tassiopoulou A; Vaiopoulos G
    Eur J Haematol; 2003 Oct; 71(4):294-8. PubMed ID: 12950240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic review.
    Shi Y; Wang E
    Arch Pathol Lab Med; 2014 Apr; 138(4):564-9. PubMed ID: 24678689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blastic plasmacytoid dendritic cell neoplasm or CD4+ CD56+ acute myeloid leukemia: A case report.
    Neji S; Lakhal FB; Salem SF; Ghali O; Neji HB; Achour M; El Borgi W; Gouider E
    Ann Biol Clin (Paris); 2024 Sep; 82(4):405-412. PubMed ID: 39210590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of primary cutaneous CD56+, TdT+, CD4+, blastic NK-cell lymphoma in a 19-year-old woman.
    Chang SE; Choi HJ; Huh J; Choi JH; Sung KJ; Moon KC; Koh JK
    Am J Dermatopathol; 2002 Feb; 24(1):72-5. PubMed ID: 11803287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and biologic features of CD4(+)CD56(+) malignancies.
    Feuillard J; Jacob MC; Valensi F; Maynadié M; Gressin R; Chaperot L; Arnoulet C; Brignole-Baudouin F; Drénou B; Duchayne E; Falkenrodt A; Garand R; Homolle E; Husson B; Kuhlein E; Le Calvez G; Sainty D; Sotto MF; Trimoreau F; Béné MC
    Blood; 2002 Mar; 99(5):1556-63. PubMed ID: 11861268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.
    Suzuki R; Nakamura S
    Leuk Res; 1999 Jul; 23(7):615-24. PubMed ID: 10400182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement.
    Suzuki R; Nakamura S; Suzumiya J; Ichimura K; Ichikawa M; Ogata K; Kura Y; Aikawa K; Teshima H; Sako M; Kojima H; Nishio M; Yoshino T; Sugimori H; Kawa K; Oshimi K;
    Cancer; 2005 Sep; 104(5):1022-31. PubMed ID: 15999368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenge in diagnosis of CD56+ lymphoproliferative disorders: two cases of CD56+CD33+ lymphoma/leukemia.
    Yang X; Wasserman PG; Bhargava A; Iqbal U; Ragnauth S; Fuchs A
    Arch Pathol Lab Med; 2004 Aug; 128(8):e100-3. PubMed ID: 15270596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia.
    Herling M; Patel KA; Teitell MA; Konopleva M; Ravandi F; Kobayashi R; Jones D
    Blood; 2008 Jan; 111(1):328-37. PubMed ID: 17890451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study.
    DiGiuseppe JA; Louie DC; Williams JE; Miller DT; Griffin CA; Mann RB; Borowitz MJ
    Am J Surg Pathol; 1997 Oct; 21(10):1223-30. PubMed ID: 9331296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retrospective analysis of 4 cases of the so-called blastic NK-cell lymphoma, with reference to the 2008 WHO classification of tumours of haematopoietic and lymphoid tissues].
    Zheng YY; Chen G; Zhou XG; Jin Y; Xie JL; Zhang SH; Zhang YN
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):600-5. PubMed ID: 21092587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.
    Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M
    Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms.
    Jaye DL; Geigerman CM; Herling M; Eastburn K; Waller EK; Jones D
    Mod Pathol; 2006 Dec; 19(12):1555-62. PubMed ID: 16998465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.